Optimal Sodium Management in Chronic Kidney Disease

Introduction to Sodium Intake Targets

The Kidney Disease: Improving Global Outcomes (KDIGO) and most international guidelines recommend a sodium intake of less than 2 g/day for CKD patients, while the Canadian Society of Nephrology suggests that patients with a mean urinary sodium excretion corresponding to 2.7-3.3 g/day have the fewest adverse outcomes 1, 2, 3, 4
A J-shaped relationship exists, where both very low (<3 g/day) and high (>7 g/day) sodium intakes increase cardiovascular mortality compared to 4-6 g/day, requiring prospective validation 5

The Japanese Society of Nephrology recommends a lower limit of 3 g/day for sodium intake, warning that extreme salt restriction could be harmful 6
The Canadian guidelines emphasize the importance of not compromising nutritional status, highlighting the need for research on the threshold where sodium restriction begins causing harm through malnutrition 3, 5

In dialysis patients, sodium intake is the primary driver of thirst and interdialytic weight gain, with a need for research on comparing sodium restriction alone versus combined sodium-fluid restriction on long-term mortality 3
For patients with sodium-wasting nephropathy, guidelines state that sodium restriction is "usually not appropriate", but optimal sodium supplementation strategies are unknown 2

The Chinese guidelines suggest substituting 25% of daily sodium with potassium may reduce blood pressure in predialysis CKD, but must be done carefully to avoid hyperkalemia 6, 7
Research is needed to define safe upper limits of dietary potassium intake when combined with RAS inhibitors, which are standard therapy in CKD 1, 2

All future sodium research in CKD should use hard clinical endpoints, have a duration of at least 2 years, and include safety monitoring for malnutrition, symptomatic hypotension, and AKI 4, 5
Studies should stratify by CKD stage and account for concurrent medications that alter sodium homeostasis 1, 5